Clinical Trial Update: Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating combinatorial pharmacogenomics testing in treatment-naïve major depressive disorder; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Washington University School of Medicine | Conditions: Major Depressive Disorder, Depression | Phase 4 | Status: TERMINATED